Skip to main content
ArticleOPEN ACCESS

Correction: PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach (RSC Adv. (2017) 7 (5046-5054) DOI: 10.1039/C6RA26511A)

RSC Advances
DOI: 10.1039/c7ra90017a
4Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Correction for ‘PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach’ by Arunkumar Rengaraj et al., RSC Adv., 2017, 7, 5046-5054.

Cite

CITATION STYLE

APA

Rengaraj, A., Subbiah, B., Haldorai, Y., Yesudhas, D., Yun, H. J., Kwon, S., … Huh, Y. S. (2017). Correction: PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach (RSC Adv. (2017) 7 (5046-5054) DOI: 10.1039/C6RA26511A). RSC Advances. Royal Society of Chemistry. https://doi.org/10.1039/c7ra90017a

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free